Development and qualification of a NGS assay for control of vector genome integrity of AAV9 drug products

Time: 10:30 am
day: Track B - Day 1 AM

Details:

  • Next Gen Sequencing Assay Applications
  • Vector Genome Integrity of AAV9, challenges and opportunities

Speakers: